However, the perseverance of our associates—and the notable success of our BD Life Sciences–Integrated Diagnostic Solutions team in developing innovative COVID-19 diagnostic testing—allowed the business to return to revenue growth in the fiscal fourth quarter and finish the year with revenues down slightly on a year-over-year basis.